JMP Securities Boosts Ocular Therapeutix (NASDAQ:OCUL) Price Target to $12.00

Ocular Therapeutix (NASDAQ:OCUL – Get Rating) had its price objective increased by JMP Securities from $11.00 to $12.00 in a research note published on Tuesday morning, The Fly reports. A number of other equities analysts have also weighed in on the stock. Robert W. Baird assumed coverage on shares of Ocular Therapeutix in a report […]

Related Keywords

Robertw Baird ,Amarpreets Sawhney , ,Raymond James Associates ,Ocular Therapeutix Inc ,Raymond James Financial Services Advisors Inc ,Ocular Therapeutix ,Get Rating ,Moderate Buy ,Therapeutix Trading Down ,James Financial Services Advisors ,Strs Ohio ,Farhad Khosravi ,Ocular Therapeutix Daily ,Nasdaq Ocul ,Hocul ,Medical ,Boost Price Target ,Jmp Securities ,